Cargando…
Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: A pilot randomized placebo-controlled trial
BACKGROUND: Methylphenidate blocks the re-uptake of dopamine by binding to the dopamine transporter in the presynaptic cell membrane and increases extracellular dopamine levels. Similarities in neuropsychologic effects between nicotine and methylphenidate make it an intriguing potential therapeutic...
Autores principales: | Hurt, Richard D, Ebbert, Jon O, Croghan, Ivana T, Schroeder, Darrell R, Sood, Amit, Hays, J Taylor |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038986/ https://www.ncbi.nlm.nih.gov/pubmed/21276244 http://dx.doi.org/10.1186/1477-5751-10-1 |
Ejemplares similares
-
Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015) -
A randomized, open-label pilot of the combination of low-level laser therapy and lorcaserin for weight loss
por: Croghan, Ivana T., et al.
Publicado: (2016) -
The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder
por: DeVito, Elise E., et al.
Publicado: (2008) -
The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
por: İsmi, Onur, et al.
Publicado: (2018) -
The Association Between Attention-Deficit Hyperactivity Disorder,
Injuries, and Methylphenidate
por: Shem-Tov, Sharon, et al.
Publicado: (2019)